Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
Ecliptic Capital
AustinPre-Seed–Series A$50K – $5M
9 people
OCV Partners
Los AngelesSeed–Series C
6 people
The Vertical Group
Berkeley HeightsSeed–Series A$250K – $5M
3 people
Vital Venture Capital
WashingtonSeries A–Growth$1M – $3M
5 people
Robo Global
New YorkSeed–Series B$500K – $2M
10 people
Access Biotechnology
New YorkSeed–Late Stage
3 people
Fides Capital
MadridSeries A–Growth$55K – $550K
ProVenture
TrondheimSeed–Series A
6 people
Wallonie Entreprendre
LiègePre-Seed–Growth
9 people
IAG Capital Partners
CharlestonSeed–Growth
4 people
Bonaventure Equity, LLC
RaleighSeed–Series A
11 people
Cancer Fund
PhoenixSeed–Series A
11 people
MESA VERDE VENTURE PARTNERS
La JollaSeed–Series A
8 people
BlueTree Venture Capital
WexfordSeries A
7 people
Boson Ventures
MelbournePre-Seed–Series A
10 people
Novalis Biotech
GhentPre-Seed–Series A
7 people
TechnoFounders
Pre-Seed–Growth
10 people
Alesta Yatırım
İstanbulSeed–Series A
Orbia Ventures
BostonSeed–Series B$1M – $6M
6 people
Shenzhen Capital Group
ShenzhenSeed–Growth$1M – $3.5M
3 people
Targeted Technology Funds
San AntonioSeed–Series A
6 people
TRICAPITAL
Scottish BordersSeed–Series A$315K – $2.5M
6 people
FusionX Ventures
San DiegoSeed–Series A
8 people
InHealth Ventures
LondonPre-Seed–Series A$500K – $3M
5 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.












































































